Literature DB >> 15797876

Specific IgE to colophony?

Joanne Elms1, David Fishwick, Edward Robinson, Sherwood Burge, Vicky Huggins, Chris Barber, Nerys Williams, Andrew Curran.   

Abstract

BACKGROUND: Colophony (rosin) is a natural product obtained from coniferous trees. It is used in a diverse range of products such as adhesives, ink, paints and soldering fluxes. Some workers exposed to colophony during soldering can develop occupational asthma; at present, no specific IgE test is available to assess sensitization to colophony.
METHODS: Serum samples were obtained from exposed symptomatic individuals (n = 7), some with a likely diagnosis of occupational asthma, exposed asymptomatic individuals (n = 10) and unexposed individuals (n = 11). Serum was tested for specific IgE antibodies against a protein extract produced following in vitro challenge of mono-mac-6 cells with colophony extract.
RESULTS: Serum from exposed symptomatic individuals showed increased binding of specific IgE antibodies to a range of colophony-cell protein conjugates [29% (2/7) of samples tested when cut-off > 0.1 or 86% (6/7) of samples tested when cut-off > 0%] compared with both the exposed asymptomatic [0% when cut-off > 0.1, or 20% when cut-off > 0% (2/10)] and the non-exposed control populations [0% when cut-off > 0.1, or 27% when cut-off > 0% (3/11)].
CONCLUSIONS: This novel approach for the production of conjugates to assess sensitization to colophony was able to detect specific IgE in colophony-exposed workers with a likely diagnosis of occupational asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797876     DOI: 10.1093/occmed/kqi047

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  1 in total

1.  Work-related respiratory symptoms and lung function among solderers in the electronics industry: a meta-analysis.

Authors:  Angelico Mendy; Janvier Gasana; Erick Forno; Edgar Ramos Vieira; Charissa Dowdye
Journal:  Environ Health Prev Med       Date:  2011-08-31       Impact factor: 3.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.